News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
178 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38488)
2025 (26337)
Month
January (3067)
February (2725)
March (2858)
April (2936)
May (3736)
June (2836)
July (2951)
August (2835)
September (2998)
October (3624)
November (3299)
December (2403)
Day
2 (165)
3 (175)
4 (151)
5 (147)
6 (92)
9 (206)
10 (178)
11 (131)
12 (134)
13 (90)
16 (130)
17 (134)
18 (124)
19 (139)
20 (123)
23 (88)
27 (84)
30 (66)
31 (46)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
2
3
4
5
6
9
10
11
12
13
16
17
18
19
20
23
27
30
31
Novo Nordisk A/S: Stock Split Information
December 10, 2013
·
1 min read
Drug Development
Portola Pharmaceuticals, Inc. Announces New Phase 2 Results Confirming Immediate, Dose-Dependent And Well-Tolerated Reversal Of Anticoagulation Activity Of XARELTO® (Rivaroxaban) With Andexanet Alfa (PRT4445*), Investigational Factor Xa Inhibitor Reversal
December 10, 2013
·
1 min read
Business
Monsanto Company And Novozymes A/S Team Up To Provide Sustainable Bioagricultural Solutions
December 10, 2013
·
1 min read
Drug Development
Preliminary Findings Of BrainStorm Cell Therapeutics Inc.'s Phase 2a Study Reported As “Extremely Optimistic”
December 10, 2013
·
1 min read
Biotech Bay
Agilent Technologies Inc. Thought Leader Award Supports Dr. Junying Yuan, Chinese Academy Of Sciences
December 10, 2013
·
1 min read
Pharm Country
Bristol-Myers Squibb Foundation Announces Two Grants To Fund Cancer Nursing Centers Of Excellence In Russia And The Czech Republic
December 10, 2013
·
1 min read
Pharm Country
Bristol-Myers Squibb Company and Otsuka America Pharmaceutical, Inc. Release: Four-Year Data From Phase 3 DASISION Trial Comparing Sprycel® (dasatinib) To Imatinib In First-Line Treatment Of Adults With Ph+ CP-CML
December 10, 2013
·
1 min read
Business
Diagnostic Healthcare Release: Strategic Acquisition Will Enhance Diagnostic Imaging In The UK
December 10, 2013
·
3 min read
BD Introduces New Automated Erythrocyte Sedimentation Rate (ESR) Instrument To Help Improve Clinical Performance
December 10, 2013
·
2 min read
Genetown
Foundation Medicine, Inc. Release: Novel And Previously Reported Genomic Alterations Identified In Clinical Multiple Myeloma Cases Using FoundationOne Heme
December 10, 2013
·
1 min read
Previous
9 of 18
Next
